Inhibition of GSH metabolism leads to a decrease in myeloid-derived suppressor cells (MDSCs) and facilitates their conversion into M1 macrophages, which promote the process of cross-presentation for tumor antigens and activate CD8+ T cells, thereby performing anti-tumor functions [14]. The gene discussed is CD8A; the disease is neoplasm.